About Nitec Pharma
Nitec Pharma is a company based in Reinach (Switzerland) founded in 2004 was acquired by Horizon Therapeutics in April 2010.. Nitec Pharma has raised $48 million across 2 funding rounds from investors including Deutsche Bank, Horizon Therapeutics and Atlas Venture.
- Headquarter Reinach, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series B
Oct 01, 2008
-
Investors
Deutsche Bank
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Horizon Therapeutics
(Apr 01, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nitec Pharma
Nitec Pharma has successfully raised a total of $48M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $22 million completed in October 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $22.0M
-
First Round
First Round
(29 Mar 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2008 | Amount | Series B - Nitec Pharma | Valuation |
investors |
|
| Mar, 2007 | Amount | Series B - Nitec Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nitec Pharma
Nitec Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Deutsche Bank, Horizon Therapeutics and Atlas Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
NGN Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nitec Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nitec Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nitec Pharma Comparisons
Competitors of Nitec Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nitec Pharma
When was Nitec Pharma founded?
Nitec Pharma was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is Nitec Pharma located?
Nitec Pharma is headquartered in Reinach, Switzerland. It is registered at Reinach, Basel-landschaft, Switzerland.
Is Nitec Pharma a funded company?
Nitec Pharma is a funded company, having raised a total of $48M across 2 funding rounds to date. The company's 1st funding round was a Series B of $26M, raised on Mar 29, 2007.
What does Nitec Pharma do?
Nitec Pharma was established in 2004 as a spin-out from Merck KGaA and is based in Reinach, Switzerland. Operations center on the specialty pharmaceutical sector, with emphasis placed on developing and commercializing treatments for chronic inflammatory and pain-related conditions. The lead product, Lodotra, functions as a circadian cytokine modulator targeted at rheumatoid arthritis management. Focus remains on advancing such therapies through clinical and market stages.
Who are Nitec Pharma's investors?
Nitec Pharma has 6 investors. Key investors include Deutsche Bank, Horizon Therapeutics, Atlas Venture, TVM Capital Life Science, and NGN Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.